Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Beijing Tiantan Biological Products Corp Ltd?
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
19.08
32.06
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Beijing Tiantan Biological Products Corp Ltd hold over its rivals?
What risks and challenges
does Beijing Tiantan Biological Products Corp Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Beijing Tiantan Biological Products Corp Ltd.
Provide an overview of the primary business activities
of Beijing Tiantan Biological Products Corp Ltd.
What unique competitive advantages
does Beijing Tiantan Biological Products Corp Ltd hold over its rivals?
What risks and challenges
does Beijing Tiantan Biological Products Corp Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Beijing Tiantan Biological Products Corp Ltd.
Provide P/S
for Beijing Tiantan Biological Products Corp Ltd.
Provide P/E
for Beijing Tiantan Biological Products Corp Ltd.
Provide P/OCF
for Beijing Tiantan Biological Products Corp Ltd.
Provide P/FCFE
for Beijing Tiantan Biological Products Corp Ltd.
Provide P/B
for Beijing Tiantan Biological Products Corp Ltd.
Provide EV/S
for Beijing Tiantan Biological Products Corp Ltd.
Provide EV/GP
for Beijing Tiantan Biological Products Corp Ltd.
Provide EV/EBITDA
for Beijing Tiantan Biological Products Corp Ltd.
Provide EV/EBIT
for Beijing Tiantan Biological Products Corp Ltd.
Provide EV/OCF
for Beijing Tiantan Biological Products Corp Ltd.
Provide EV/FCFF
for Beijing Tiantan Biological Products Corp Ltd.
Provide EV/IC
for Beijing Tiantan Biological Products Corp Ltd.
Show me price targets
for Beijing Tiantan Biological Products Corp Ltd made by professional analysts.
What are the Revenue projections
for Beijing Tiantan Biological Products Corp Ltd?
How accurate were the past Revenue estimates
for Beijing Tiantan Biological Products Corp Ltd?
What are the Net Income projections
for Beijing Tiantan Biological Products Corp Ltd?
How accurate were the past Net Income estimates
for Beijing Tiantan Biological Products Corp Ltd?
What are the EPS projections
for Beijing Tiantan Biological Products Corp Ltd?
How accurate were the past EPS estimates
for Beijing Tiantan Biological Products Corp Ltd?
What are the EBIT projections
for Beijing Tiantan Biological Products Corp Ltd?
How accurate were the past EBIT estimates
for Beijing Tiantan Biological Products Corp Ltd?
Compare the revenue forecasts
for Beijing Tiantan Biological Products Corp Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Beijing Tiantan Biological Products Corp Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Beijing Tiantan Biological Products Corp Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Beijing Tiantan Biological Products Corp Ltd compared to its peers.
Compare the P/E ratios
of Beijing Tiantan Biological Products Corp Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Beijing Tiantan Biological Products Corp Ltd with its peers.
Analyze the financial leverage
of Beijing Tiantan Biological Products Corp Ltd compared to its main competitors.
Show all profitability ratios
for Beijing Tiantan Biological Products Corp Ltd.
Provide ROE
for Beijing Tiantan Biological Products Corp Ltd.
Provide ROA
for Beijing Tiantan Biological Products Corp Ltd.
Provide ROIC
for Beijing Tiantan Biological Products Corp Ltd.
Provide ROCE
for Beijing Tiantan Biological Products Corp Ltd.
Provide Gross Margin
for Beijing Tiantan Biological Products Corp Ltd.
Provide Operating Margin
for Beijing Tiantan Biological Products Corp Ltd.
Provide Net Margin
for Beijing Tiantan Biological Products Corp Ltd.
Provide FCF Margin
for Beijing Tiantan Biological Products Corp Ltd.
Show all solvency ratios
for Beijing Tiantan Biological Products Corp Ltd.
Provide D/E Ratio
for Beijing Tiantan Biological Products Corp Ltd.
Provide D/A Ratio
for Beijing Tiantan Biological Products Corp Ltd.
Provide Interest Coverage Ratio
for Beijing Tiantan Biological Products Corp Ltd.
Provide Altman Z-Score Ratio
for Beijing Tiantan Biological Products Corp Ltd.
Provide Quick Ratio
for Beijing Tiantan Biological Products Corp Ltd.
Provide Current Ratio
for Beijing Tiantan Biological Products Corp Ltd.
Provide Cash Ratio
for Beijing Tiantan Biological Products Corp Ltd.
What is the historical Revenue growth
over the last 5 years for Beijing Tiantan Biological Products Corp Ltd?
What is the historical Net Income growth
over the last 5 years for Beijing Tiantan Biological Products Corp Ltd?
What is the current Free Cash Flow
of Beijing Tiantan Biological Products Corp Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Beijing Tiantan Biological Products Corp Ltd.
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
CN |
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
|
37.9B CNY | 17.1 | ||
FR |
Pharnext SCA
OTC:PNEXF
|
6T USD | -220 752.2 |
|
|
US |
Abbvie Inc
NYSE:ABBV
|
312.3B USD | 23.6 |
|
|
US |
Amgen Inc
NASDAQ:AMGN
|
145.2B USD | 31 |
|
|
US |
Gilead Sciences Inc
NASDAQ:GILD
|
112.1B USD | 9.9 |
|
|
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
106.5B USD | 23.1 |
|
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | -492.5 |
|
AU |
CSL Ltd
ASX:CSL
|
135.1B AUD | 24.4 |
|
|
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.9B USD | 17.1 |
|
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | -52.1 |
|
NL |
argenx SE
XBRU:ARGX
|
38.7B EUR | -108.9 |
|
EBIT Growth | EV/EBIT to Growth | |||||
---|---|---|---|---|---|---|
CN |
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
|
Average EV/EBIT:
20.9
17.1
|
8%
|
2.1 | ||
FR |
Pharnext SCA
OTC:PNEXF
|
Negative Multiple: -220 752.2 | N/A | N/A |
|
|
US |
Abbvie Inc
NYSE:ABBV
|
23.6
|
24%
|
1 |
|
|
US |
Amgen Inc
NASDAQ:AMGN
|
31
|
24%
|
1.3 |
|
|
US |
Gilead Sciences Inc
NASDAQ:GILD
|
9.9
|
10%
|
1 |
|
|
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
23.1
|
13%
|
1.8 |
|
|
US |
E
|
Epizyme Inc
F:EPE
|
Negative Multiple: -492.5 | N/A | N/A |
|
AU |
CSL Ltd
ASX:CSL
|
24.4
|
16%
|
1.5 |
|
|
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
17.1
|
12%
|
1.4 |
|
|
US |
S
|
Seagen Inc
F:SGT
|
Negative Multiple: -52.1 | N/A | N/A |
|
NL |
argenx SE
XBRU:ARGX
|
Negative Multiple: -108.9 | N/A | N/A |
|
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.